The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study

Table 5 Multivariate analysis for pRR and biomarkers^#

Treatment*	Independent Factor	OR	pValue**
DEC (n = 58)	ER	5.2	< 0.001
DEC (n = 58)	HER2	0.2	0.026
EFC (n = 37)	ER	26.0	0.007
VFC (n = 23)	ER	10.7	0.047
All patients (n = 118)	ER	11.6	< 0.001

^# pRR: pathologic response rate
* D docetaxel, E epirubicin, C cyclophosphamide, F 5-Fluorouracil, V vinorelbine or vincristine
**p < 0.05 is considered statistically significant

ISSN: 1471-2407